FutureChem Co.,Ltd Company Description

FutureChem Co.,Ltd engages in the research and development, production, and sale of radiopharmaceuticals in South Korea.

The company offers PDVUE, a positron emission tomography (PET) radiopharmaceutical diagnostic medicine for Parkinson’s disease; Alzavue, a radiopharmaceutical for Aalzheimer's disease; and [18F]FDG, a PET radiopharmaceutical for the treatment of cancer.

Its products in pipeline include 18F-FC303 and 177Lu-FC705 for the treatment of prostate cancer; 18F-FMT for the treatment of brain tumor; 18F-FC505, for the treatment of atherosclerotic plaque; and 18F-FC211, for the treatment of Alzheimer’s disease.

FutureChem Co.,Ltd was founded in 1999 and is headquartered in Seoul, South Korea.

FutureChem Co.,Ltd

Country	South Korea
Founded	1999
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
CEO	Dae-Yoon Chi

Contact Details

Address: PyeongHwa Building Seoul, 04794 South Korea
Phone	82 2 497 3114
Website	futurechem.co.kr

Stock Details

Ticker Symbol	220100
Exchange	KOSDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	KRW
ISIN Number	KR7220100002
SIC Code	2835

Key Executives

Name	Position
Dae-Yoon Chi	Chief Executive Officer